Cooper, David A <br/><br/>
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development.  [electronic resource] 

 -  The Lancet. Infectious diseases  Jul 2004 
 - 426-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1473-3099 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(04)01058-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--drug therapy<br/>Amino Acid Sequence<br/>Cell Fusion<br/>Clinical Trials as Topic<br/>Enfuvirtide<br/>HIV Envelope Protein gp41--chemistry<br/>HIV Fusion Inhibitors--chemistry<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Peptide Fragments--chemistry<br/>Peptides--chemistry<br/>Virus Physiological Phenomena<br/>Viruses--drug effects